Mask Investments Limited (NSE:MASKINVEST)

Revance Therapeutics Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Other Revenue	4.1	7.43	3.08	2.2	1.34
Revenue	4.1	7.43	3.08	2.2	1.34
Revenue Growth (YoY)	-44.77%	140.80%	40.28%	64.51%	-13.56%
Gross Profit	4.1	7.43	3.08	2.2	1.34
Selling, General & Admin	2.92	6.17	1.36	0.68	0.55
Other Operating Expenses	0.75	0.81	0.7	0.64	0.69
Operating Expenses	3.66	6.98	2.06	1.32	1.25
Operating Income	0.44	0.45	1.03	0.88	0.09
Interest Expense	-0	-0.17	-0.25	-0	-0.01
Interest & Investment Income	-	-	0.01	-	-
Other Non Operating Income (Expenses)	0.04	0.01	-0	-0	-0
EBT Excluding Unusual Items	0.47	0.28	0.79	0.88	0.08
Pretax Income	0.47	0.28	0.79	0.88	0.08
Income Tax Expense	0.13	0.07	0.2	0.86	0.02
Net Income	0.35	0.21	0.59	0.02	0.06
Net Income to Common	0.35	0.21	0.59	0.02	0.06
Net Income Growth	64.29%	-64.38%	2339.47%	-58.17%	38.84%
Shares Outstanding (Basic)	3	3	3	3	3
Shares Outstanding (Diluted)	3	3	3	3	3
Shares Change (YoY)	4.54%	-1.69%	-	-	-
EPS (Basic)	0.11	0.07	0.19	0.01	0.02
EPS (Diluted)	0.11	0.07	0.19	0.01	0.02
EPS Growth	57.14%	-63.16%	2298.99%	-58.17%	38.84%
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	10.66%	6.02%	33.33%	40.18%	6.70%
Profit Margin	8.41%	2.83%	19.12%	1.10%	4.32%
EBIT	0.44	0.45	1.03	0.88	0.09
EBIT Margin	10.66%	6.02%	33.33%	40.18%	6.70%
Effective Tax Rate	27.06%	25.27%	25.18%	97.26%	27.88%
Revenue as Reported	4.14	7.43	3.09	2.2	1.34
Advertising Expenses	-	-	0.05	0.04	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.